PARIS, Feb 1 (Reuters) - Sanofi SASY.PA /Regeneron REGN.O :
* Sanofi and Regeneron Pharmaceuticals, Inc. today announced that Health Canada approved Kevzara(TM)
* Product approved for treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more biologic or non-biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
Source text on Eikon: